Methylamine

Methylamine

SCHEMBL5848002

CCc1cccc(O)c1.CN

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.61
DRD2 P14416 3/20 0.57
DRD1 P21728 2/20 0.57
TAAR1 Q96RJ0 1/20 0.57
CYP3A4 P08684 2/20 0.55
CYP1A2 P05177 1/20 0.55
PKM P14618 1/20 0.55
ALOX15 P16050 1/20 0.55
NFKB1 P19838 1/20 0.55
MAPK1 P28482 1/20 0.55
LMNA P02545 2/20 0.53
KMT2A Q03164 1/20 0.53
KDM4E B2RXH2 1/20 0.53
MAPT P10636 1/20 0.53
BLM P54132 1/20 0.53
PMP22 Q01453 1/20 0.53
CHRM2 P08172 1/20 0.52
CHRM1 P11229 1/20 0.52
CHRM3 P20309 1/20 0.52
DRD3 P35462 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29462919 0.95
SCHEMBL17847703 0.95 ENPP2 (0.60) ENPP2DRD2DRD1TAAR1CYP3A4
SCHEMBL51757 0.95
Hydrochloric Acid SCHEMBL7072318 0.93 ENPP2 (0.58) ENPP2DRD2DRD1TAAR1CYP3A4
Methyl Alcohol SCHEMBL27529799 0.93 ENPP2 (0.58) ENPP2DRD2DRD1TAAR1CYP3A4
Ammonia Solution, Strong SCHEMBL269070 0.93 ENPP2 (0.58) ENPP2DRD2DRD1TAAR1CYP3A4
SCHEMBL5994875 0.93 ENPP2 (0.58) ENPP2DRD2DRD1TAAR1CYP3A4
SCHEMBL29152336 0.93 ENPP2 (0.58) ENPP2DRD2DRD1TAAR1CYP3A4
Hydrochloric Acid SCHEMBL6039838 0.91 ENPP2 (0.56) ENPP2DRD2DRD1TAAR1CYP3A4
Hydrochloric Acid SCHEMBL27504560 0.89 ENPP2 (0.54) ENPP2DRD2DRD1TAAR1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7112605-B2 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof Research Institute of Materia Medica Chinese Acadamy of Medical Sciences (CN) 2006-09-26 US disclosed
US-20040029951-A1 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof RESEARCH INSTITUTE OF MATERIAL MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES; 2004-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029951-A1 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof PTGS1, PTGS2, PTGER1 ENPP2 2993/4885DRD2 1261/4885DRD1 1403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.